About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- ceftriaxone
- Procedure number
- PSUSA/00000613/202305
- Regulatory outcome
- Variation
Documents
Ceftriaxone : List of nationally authorised medicinal products - PSUSA/00000613/202305
English (EN) (166.03 KB - PDF)
Ceftriaxone : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00000613/202305
English (EN) (24.22 KB - PDF)
български (BG) (98.59 KB - PDF)
español (ES) (24.74 KB - PDF)
čeština (CS) (94.61 KB - PDF)
dansk (DA) (25.02 KB - PDF)
Deutsch (DE) (26.05 KB - PDF)
eesti keel (ET) (25.5 KB - PDF)
ελληνικά (EL) (89.78 KB - PDF)
français (FR) (24.49 KB - PDF)
Gaeilge (IE) (24.83 KB - PDF)
hrvatski (HR) (87.59 KB - PDF)
italiano (IT) (25.95 KB - PDF)
latviešu valoda (LV) (95.26 KB - PDF)
lietuvių kalba (LT) (92.41 KB - PDF)
magyar (HU) (88.56 KB - PDF)
Malti (MT) (99.17 KB - PDF)
Nederlands (NL) (25.36 KB - PDF)
polski (PL) (93.88 KB - PDF)
português (PT) (24.12 KB - PDF)
română (RO) (90.4 KB - PDF)
slovenčina (SK) (93.96 KB - PDF)
slovenščina (SL) (88.38 KB - PDF)
Suomi (FI) (25.33 KB - PDF)
svenska (SV) (24.37 KB - PDF)